{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:51:01Z","timestamp":1789588261019,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-023-00778-7","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T21:29:26Z","timestamp":1677014966000},"page":"368-373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A case of minimal change nephrotic syndrome complicated by Kimura disease treated with rituximab"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8297-5247","authenticated-orcid":false,"given":"Ryuto","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Matuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"778_CR1","first-page":"179","volume":"37","author":"T Kimura","year":"1948","unstructured":"Kimura T. Unusual granulation combined with hyperplastic change of lymphatic tissue. Trans Soc Pathol Jpn. 1948;37:179\u201380.","journal-title":"Trans Soc Pathol Jpn"},{"key":"778_CR2","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/j.1365-2133.1997.tb01562.x","volume":"137","author":"K Katagiri","year":"1997","unstructured":"Katagiri K, Itami S, Hatano Y, Yamaguchi T, Takayasu S. In vivo expression of IL-4, IL-5, IL-13 and IFN-\u03b3 mRNAs in peripheral blood mononuclear cells and effect of cyclosporin A in a patient with Kimura\u2019s disease. Br J Dermatol. 1997;137:972\u20137.","journal-title":"Br J Dermatol"},{"issue":"11","key":"778_CR3","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/00000478-198811000-00005","volume":"12","author":"T Kuo","year":"1988","unstructured":"Kuo T, Shih Y, Chan L. Kimura\u2019s disease. Involvement of regional lymph nodes and distinction from angiolymphoid hyperplasia with eosinophilia. Am J Surg Pathol. 1988;12(11):843\u201354 (PMID: 2461103).","journal-title":"Am J Surg Pathol"},{"key":"778_CR4","first-page":"211","volume":"18","author":"A Yamada","year":"1982","unstructured":"Yamada A, Mitsuhashi K, Miyakawa Y, Kosaka K, Takehara K, Iijima M, Tanaka K, Shibata S. Membranous glomerulonephritis associated with eosinophilic lymphfolliculosis of the skin (Kimura\u2019s disease): report of a case and review of the literature. Clin Nephrol. 1982;18:211\u20135.","journal-title":"Clin Nephrol"},{"issue":"6","key":"778_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s004670050799","volume":"14","author":"K Rajpoot","year":"2000","unstructured":"Rajpoot K, Pahl M, Clark J. Nephrotic syndrome associated with Kimura disease. Pediatr Nephrol. 2000;14(6):486\u20138. https:\/\/doi.org\/10.1007\/s004670050799.","journal-title":"Pediatr Nephrol"},{"key":"778_CR6","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1093\/ndt\/13.9.2358","volume":"13","author":"SN Natov","year":"1998","unstructured":"Natov SN, Strom JA, Ucci A. Relapsing nephrotic syndrome in a patient with Kimura\u2019s disease and IgA glomerulonephritis. Nephrol Dial Transplant. 1998;13:2358\u201363. https:\/\/doi.org\/10.1093\/ndt\/13.9.2358.","journal-title":"Nephrol Dial Transplant"},{"key":"778_CR7","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1053\/j.ajkd.2009.03.019","volume":"54","author":"M Abdel-Hafez","year":"2009","unstructured":"Abdel-Hafez M, Shimada M, Lee PY, Johnson RJ, Garin EH. Idiopathic nephrotic syndrome and atopy: is there a common link? Am J Kidney Dis. 2009;54:945\u201353. https:\/\/doi.org\/10.1053\/j.ajkd.2009.03.019.","journal-title":"Am J Kidney Dis"},{"key":"778_CR8","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1681\/ASN.2006070710","volume":"18","author":"KW Lai","year":"2007","unstructured":"Lai KW, Wei CL, Tan LK, Tan PH, Chiang GSC, Lee CGL, Jordan SC, Yap HK. Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol. 2007;18:1476\u201385. https:\/\/doi.org\/10.1681\/ASN.2006070710.","journal-title":"J Am Soc Nephrol"},{"key":"778_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/tropej\/fmu040","volume":"60","author":"OP Mishra","year":"2014","unstructured":"Mishra OP, Teli AS, Singh U, Abhinay A, Prasad R. Serum immunoglobulin E and interleukin-13 levels in children with idiopathic nephrotic syndrome. J Trop Pediatr. 2014;60:467\u201371. https:\/\/doi.org\/10.1093\/tropej\/fmu040.","journal-title":"J Trop Pediatr"},{"key":"778_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/MAJ.0b013e3181b471e4","volume":"338","author":"YN Shao","year":"2009","unstructured":"Shao YN, Chen YC, Jenq CC, Hsu HH, Chang MY, Tian YC, Fang JT, Yang CW. Serum immunoglobulin E can predict minimal change disease before renal biopsy. Am J Med Sci. 2009;338:264\u20137. https:\/\/doi.org\/10.1097\/MAJ.0b013e3181b471e4.","journal-title":"Am J Med Sci"},{"key":"778_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s10157-007-0484-5","volume":"11","author":"T Takei","year":"2007","unstructured":"Takei T, Koike M, Suzuki K, Shirota S, Itabashi M, Ohtsubo S, Sugiura H, Suzuki K, Kojima C, Takahashi M, Ino J, Ogawa T, Uchida K, Tsuchiya K, Yumura W, Nitta K. The characteristics of relapse in adult-onset minimal-change nephrotic syndrome. Clin Exp Nephrol. 2007;11:214\u20137. https:\/\/doi.org\/10.1007\/s10157-007-0484-5.","journal-title":"Clin Exp Nephrol"},{"key":"778_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000185065","volume":"49","author":"K Matsumoto","year":"1988","unstructured":"Matsumoto K, Katayama H, Hatano M. Minimal-change nephrotic syndrome associated with subcutaneous eosinophilic lymphoid granuloma (Kimura\u2019s disease). Nephron. 1988;49:251\u20134. https:\/\/doi.org\/10.1159\/000185065.","journal-title":"Nephron"},{"key":"778_CR13","first-page":"119","volume":"37","author":"O Matsuda","year":"1992","unstructured":"Matsuda O, Makiguchi K, Ishibashi K, Chida Y, Ida T, Matsuda K, Tomita K, Marumo F, Hiruma M. Long-term effects of steroid treatment on nephrotic syndrome associated with Kimura\u2019s disease and a review of the literature. Clin Nephrol. 1992;37:119\u201323.","journal-title":"Clin Nephrol"},{"key":"778_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000188268","volume":"68","author":"S Atar","year":"1994","unstructured":"Atar S, Oberman AS, Ben-Izhak O, Flatau E. Recurrent nephrotic syndrome associated with Kimura\u2019s disease in a young non-oriental male. Nephron. 1994;68:259\u201361. https:\/\/doi.org\/10.1159\/000188268.","journal-title":"Nephron"},{"key":"778_CR15","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1093\/ndt\/11.7.1349","volume":"11","author":"K Sud","year":"1996","unstructured":"Sud K, Saha T, Das A, Kakkar N, Jha V, Kohli HS, Sakhuja V. Kimura\u2019s disease and minimal-change nephrotic syndrome. Nephrol Dial Transplant. 1996;11:1349\u201351.","journal-title":"Nephrol Dial Transplant"},{"key":"778_CR16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/BF02480644","volume":"1","author":"A Yoshida","year":"1997","unstructured":"Yoshida A, Takeda A, Koyama K, Ohtsuka Y, Morozumi K, Oikawa T. Kimura\u2019s disease associated with minimal change nephrotic syndrome: a case report. Clin Exp Nephrol. 1997;1:292\u20136.","journal-title":"Clin Exp Nephrol"},{"key":"778_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3960\/jslrt.17028","volume":"57","author":"T Matsuo","year":"2017","unstructured":"Matsuo T, Tanaka T, Kinomura M. Nephrotic syndrome during the tapering of oral steroids after pathological diagnosis of Kimura disease from a lacrimal gland mass: case report and review of 10 Japanese patients. J Clin Exp Hematop. 2017;57:147\u201352. https:\/\/doi.org\/10.3960\/jslrt.17028.","journal-title":"J Clin Exp Hematop"},{"key":"778_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4103\/1319-2442.252921","volume":"30","author":"MR Balwani","year":"2019","unstructured":"Balwani MR, Bawankule CP, Pasari A, Tolani P, Vakil S, Yadav R. Minimal change disease and Kimura\u2019s disease responding to tacrolimus therapy. Saudi J Kidney Dis Transpl. 2019;30:254\u20137.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"778_CR19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12882-018-1123-y","volume":"19","author":"S Ren","year":"2018","unstructured":"Ren S, Li XY, Wang F, Zhang P, Zhang Y, Li GS, Wang L, Zhong X. Nephrotic syndrome associated with Kimura\u2019s disease: a case report and literature review. BMC Nephrol. 2018;19:316. https:\/\/doi.org\/10.1186\/s12882-018-1123-y.","journal-title":"BMC Nephrol"},{"key":"778_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000501638","volume":"143","author":"S Yang","year":"2019","unstructured":"Yang S, Wang J, Chen Y, Jiang Z, Zhong T, Dong Y, Guan W, Chen W. Concurrent kidney glomerular and interstitial lesions associated with Kimura\u2019s disease. Nephron. 2019;143:92\u20139. https:\/\/doi.org\/10.1159\/000501638.","journal-title":"Nephron"},{"key":"778_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4274\/tjh.galenos.2020.2020.0477","volume":"38","author":"R Eren","year":"2021","unstructured":"Eren R, C\u00f6mert E, Mansuro\u011flu \u0130, Do\u011fan EE, Kad\u0131o\u011flu G. Kimura disease associated with minimal change disease. Turk J Haematol. 2021;38:165\u20136. https:\/\/doi.org\/10.4274\/tjh.galenos.2020.2020.0477.","journal-title":"Turk J Haematol"},{"issue":"3","key":"778_CR22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1053\/ajkd.2002.31400","volume":"39","author":"M Nakayama","year":"2022","unstructured":"Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fujimi S. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis. 2022;39(3):503\u201312. https:\/\/doi.org\/10.1053\/ajkd.2002.31400.","journal-title":"Am J Kidney Dis"},{"key":"778_CR23","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1097\/MD.0000000000000300","volume":"93","author":"Y Iwabuchi","year":"2014","unstructured":"Iwabuchi Y, Takei T, Moriyama T, Itabashi M, Nitta K. Long-term prognosis of adult patients with steroid-dependent minimal change nephrotic syndrome following rituximab treatment. Medicine. 2014;93:e300. https:\/\/doi.org\/10.1097\/MD.0000000000000300.","journal-title":"Medicine"},{"key":"778_CR24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000331913","volume":"96","author":"D Simon","year":"2012","unstructured":"Simon D, Simon HU. New drug targets in atopic dermatitis. Chem Immunol Allergy. 2012;96:126\u201331. https:\/\/doi.org\/10.1159\/000331913.","journal-title":"Chem Immunol Allergy"},{"key":"778_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jaci.2007.11.016","volume":"121","author":"D Simon","year":"2008","unstructured":"Simon D, H\u00f6sli S, Kostylina G, Yawalkar N, Simon HU. Anti-CD20 (rituximab) treatment improves atopic eczema. J Allergy Clin Immunol. 2008;121:122\u20138. https:\/\/doi.org\/10.1016\/j.jaci.2007.11.016.","journal-title":"J Allergy Clin Immunol"},{"key":"778_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000515644","volume":"11","author":"R Vissing-Uhre","year":"2021","unstructured":"Vissing-Uhre R, Hansen A, Frevert S, Hansen D. Rituximab treatment in a patient with Kimura disease and membranous nephropathy: case report. Case Rep Nephrol Dial. 2021;11:116\u201323. https:\/\/doi.org\/10.1159\/000515644.","journal-title":"Case Rep Nephrol Dial"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-023-00778-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-023-00778-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-023-00778-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T10:12:19Z","timestamp":1698833539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-023-00778-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["778"],"URL":"https:\/\/doi.org\/10.1007\/s13730-023-00778-7","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"assertion":[{"value":"21 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have declared no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The procedures performed in this study that involve human participants were performed in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards and the ethical standards of the institutional and national research committee where the studies were conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all patients included in this study. Additional informed consent was obtained from all patients with identifying information included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}